Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study.
Zhang L, Meng L, Liu B, Zhang Y, Zhu H, Cui J, Sun A, Hu Y, Jin J, Jiang H, Zhang X, Li Y, Liu L, Zhang W, Liu X, Gu J, Qiao J, Ouyang G, Liu X, Luo J, Jiang M, Xie X, Li J, Zhao C, Zhang M, Yang T, Wang J. Zhang L, et al. Among authors: meng l. Clin Cancer Res. 2021 Jan 1;27(1):70-77. doi: 10.1158/1078-0432.CCR-20-1600. Epub 2020 Sep 14. Clin Cancer Res. 2021. PMID: 32928796
Adolescents experienced more treatment failure than children with chronic myeloid leukemia receiving imatinib as frontline therapy: a retrospective multicenter study.
Dou X, Zheng F, Zhang L, Jin J, Zhang Y, Liu B, Meng L, Zhu X, Lu Z, Jia Y, Liu H, Lin H, Zhou L, Zhao X, Yang W, Sun H, Qian S, Ma H, Du X, Bai Q, Xu N, Meng F, Jia Z, Di H, Zhang L, Jiang Q. Dou X, et al. Among authors: meng f, meng l. Ann Hematol. 2021 Sep;100(9):2215-2228. doi: 10.1007/s00277-021-04544-6. Epub 2021 Jun 5. Ann Hematol. 2021. PMID: 34089385
Health-related quality of life in children with chronic myeloid leukemia in the chronic phase.
Zheng F, Dou X, Zhang L, Jin J, Zhang Y, Liu B, Meng L, Zhu X, Lu Z, Jia Y, Liu H, Lin H, Zhou L, Zhao X, Yang W, Sun H, Qian S, Ma H, Wu R, Zhang L, Jiang Q. Zheng F, et al. Among authors: meng l. J Cancer Res Clin Oncol. 2022 Feb;148(2):341-350. doi: 10.1007/s00432-021-03832-y. Epub 2021 Oct 29. J Cancer Res Clin Oncol. 2022. PMID: 34714411
Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
Jiang Q, Li Z, Qin Y, Li W, Xu N, Liu B, Zhang Y, Meng L, Zhu H, Du X, Chen S, Liang Y, Hu Y, Liu X, Song Y, Men L, Chen Z, Niu Q, Wang H, Lu M, Yang D, Zhai Y, Huang X. Jiang Q, et al. Among authors: meng l. J Hematol Oncol. 2022 Aug 18;15(1):113. doi: 10.1186/s13045-022-01334-z. J Hematol Oncol. 2022. PMID: 35982483 Free PMC article. Clinical Trial.
Monitoring of leukemia stem cells in chronic myeloid leukemia patients.
Cui J, Zhu Z, Liu S, Li Q, Meng L, Cheng H, Zhong Z, Li W, You Y, Zhu X, Zou P. Cui J, et al. Among authors: meng l. Leuk Lymphoma. 2018 Sep;59(9):2264-2266. doi: 10.1080/10428194.2017.1421755. Epub 2018 Jan 16. Leuk Lymphoma. 2018. PMID: 29334838 No abstract available.
7,158 results